Editas Medicine Inc. logo

Editas Medicine Inc.

EDIT | NASDAQ
Chart Builder DCF Calculator
$2.87
+$0.04 (+1.41%)
Sep 22, 2026, 12:09 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-160.06M -237.09M -153.22M -220.43M -192.5M -115.98M
Depreciation & Amortization
5.28M 5.81M 6.06M 6.34M 5.05M 3.96M
Stock-Based Compensation
10M 21.42M 19.8M 29.29M 43.4M 23.16M
Other Working Capital
-29.43M 11.82M 4.94M 8.69M -22.71M -91.79M
Other Non-Cash Items
10.77M -3.87M -3.23M -724K 1.66M 27.6M
Deferred Income Tax
n/a n/a n/a n/a n/a -16.37M
Change in Working Capital
-31.23M 3.45M -1.59M 8.18M -21.41M -102.22M
Operating Cash Flow
-165.24M -210.28M -132.18M -177.35M -163.8M -179.84M
Capital Expenditures
-607K -8.83M -4.72M -4.12M -7.98M -7.16M
Cash Acquisitions
269K n/a n/a 18K 46.49M 12K
Purchase of Investments
n/a -86.22M -258.52M -315.19M -408.89M -458.4M
Sales Maturities Of Investments
139.01M 257.19M 259.51M 433.35M 362.4M 325.03M
Other Investing Acitivies
n/a n/a n/a n/a -46.49M n/a
Investing Cash Flow
138.67M 162.15M -3.73M 114.07M -54.47M -140.52M
Debt Repayment
-2.87M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 960K n/a 32.65M 20.4M
Financial Cash Flow
40.47M 56.03M 118.04M 1.28M 282.11M 224.12M
Net Cash Flow
13.9M 7.89M -17.87M -62M 63.84M -96.24M
Free Cash Flow
-165.85M -219.11M -136.9M -181.47M -171.78M -187.01M
Adj. Free Cash Flow
-175.85M -240.53M -156.7M -210.76M -215.18M -210.16M
Maintenance CapEx
n/a -8.83M n/a -4.12M -7.98M n/a
Growth CapEx
-607K n/a -4.72M n/a n/a -7.16M
Owner Earnings
-165.24M -219.11M -132.18M -181.47M -171.78M -179.84M

© 2026 bestshares.com. All rights reserved.